Filing Flows › Sanuwave Health (SNWV) › R&D spending
Sanuwave Health (SNWV) R&D spending by quarter
Sanuwave Health's R&D spending was $628K in Q2 2026 (second quarter 2026), -5% from Q1 2026. Over the last 7 quarters it ranged from $154K (Q4 2024) to $660K (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $628K | -5% | +224% |
| Q1 2026 | $660K | +9% | +217% |
| Q4 2025 | $606K | +76% | +294% |
| Q3 2025 | $345K | +78% | — |
| Q2 2025 | $194K | -7% | — |
| Q1 2025 | $208K | +35% | — |
| Q4 2024 | $154K | — | — |
Q2 2026 at a glance
Sanuwave Health, Q2 2026: revenue $9.7M (-3% year over year), operating margin -2.9%, net loss $682K, operating cash flow $425K. The chart follows the revenue to costs, profit and cash.
Questions
What is Sanuwave Health's R&D spending?
Sanuwave Health's R&D spending was $628K in Q2 2026 (second quarter 2026), -5% from Q1 2026.
How has Sanuwave Health's R&D spending changed?
Over the last 7 quarters it ranged from $154K (Q4 2024) to $660K (Q1 2026).